The effect of scopolamine on mental performance during microgravity simulation [Abstract in English]
2006
Objective: The optimization of mental performance
and the minimization of errors can save lives and reduce
the costs of a space mission. Cognition was evaluated by
means of a psychological test, the Manikin Test, under the
effect of scopolamine, a drug widely used to prevent or
minimize the symptomatology of Space Motion Sickness,
during microgravity simulation.
Methods: 6o HDT (head-down tilt) was used to simulate
some of the effects of microgravity. A double-blind
and randomized study evaluated the effect of 0.45 mg of
Scopolamine on mental performance during microgravity
simulation (n = 15).
Results: Scopolamine failed to decrease mental performance
during microgravity simulation when measured
by means of a psychological test.
Conclusion: Further studies are needed to better clarify
the interaction between Scopolamine and HDT, which will
allow the development of a more effective way to prevent or to minimize the symptomatology related to space motion
sickness.
KEY WORDS: MENTAL PERFORMANCE, SCOPOLAMINE,
MICROGRAVITY, 6o HEAD-DOWN TILT, SPACE MOTION
SICKNESS.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI